Evidence map›Paper›PMID 32676816›Full record

ArticleDiabetologia2020

Human enteroviral infection impairs autophagy in clonal INS(832/13) cells and human pancreatic islet cells.

Anya Wernersson, Luis Sarmiento, Elaine Cowan, Malin Fex, Corrado M Cilio

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  3. Article
  4. β-Cell autophagy in the pathogenesis of type 1 diabetes.American journal of physiology. Endocrinology and metabolism · 2021
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anya WernerssonUnit of Molecular Metabolism, Department of Clinical Sciences, Lund University Diabetes Centre, Clinical Research Center 91:10, Jan Waldenströmsgata 35, SE-21428, Malmö, Sweden.ORCID 0000-0003-1608-1581
Luis SarmientoImmunovirology Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden.ORCID 0000-0002-3694-1211
Elaine CowanUnit of Molecular Metabolism, Department of Clinical Sciences, Lund University Diabetes Centre, Clinical Research Center 91:10, Jan Waldenströmsgata 35, SE-21428, Malmö, Sweden.ORCID 0000-0003-3939-8864
Malin FexUnit of Molecular Metabolism, Department of Clinical Sciences, Lund University Diabetes Centre, Clinical Research Center 91:10, Jan Waldenströmsgata 35, SE-21428, Malmö, Sweden. malin.fex@med.lu.se.ORCID 0000-0003-0675-7576
Corrado M CilioImmunovirology Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden.ORCID 0000-0002-2768-740X
Lund University · SE

Funding

Stiftelsen för Strategisk Forskning IRC15-0067Vetenskapsrådet 349-2006-237
6 · The paper itself

Abstract

aim/hypothesisHuman enteroviral infections are suggested to be associated with type 1 diabetes. However, the mechanism by which enteroviruses can trigger disease remains unknown. The present study aims to investigate the impact of enterovirus on autophagy, a cellular process that regulates beta cell homeostasis, using the clonal beta cell line INS(832/13) and human islet cells as in vitro models.

methodsINS(832/13) cells and human islet cells were infected with a strain of echovirus 16 (E16), originally isolated from the stool of a child who developed type 1 diabetes-associated autoantibodies. Virus production and release was determined by 50% cell culture infectious dose (CCID

resultsE16-infected INS(832/13) cells displayed an accumulation of autophagosomes, compared with non-treated (NT) cells (grown in complete RPMI1640 containing 11.1 mmol/l glucose) (32.1 ± 1.7 vs 21.0 ± 1.2 μm CONCLUSIONS/

interpretationEnteroviruses disrupt beta cell autophagy by impairing the later stages of the autophagic pathway, without influencing expression of key genes involved in core autophagy machinery. This results in increased viral replication, non-lytic viral spread and accumulation of autophagic structures, all of which may contribute to beta cell demise and type 1 diabetes. Graphical abstract.

Indexed as

AutophagyBlotting, WesternFemaleHumansIslets of LangerhansMalePancreasVirus ReplicationAutophagyBeta cellsEnterovirusInsulin secretionLysosomesType 1 diabetesViral replicationVirus spread

Identifiers

PMID32676816
PMCPMC7527364
OpenAlexW3043073711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.